6-[1-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[1-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;cyclopropanecarbonyl chloride
C36H33Br2ClN14O2 — CID 159388307
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[1-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[1-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;cyclopropanecarbonyl chloride
6-[1-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[1-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;cyclopropanecarbonyl chloride (PubChem CID 159388307) has the molecular formula C36H33Br2ClN14O2 and a molecular weight of 889.02 g/mol. Its IUPAC name is 6-[1-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[1-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;cyclopropanecarbonyl chloride.
Molecular Properties
| Compound Name | 6-[1-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[1-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;cyclopropanecarbonyl chloride |
|---|---|
| PubChem CID | 159388307 |
| Molecular Formula | C36H33Br2ClN14O2 |
| Molecular Weight | 889.02 g/mol |
| Exact Mass | 886.10 |
| IUPAC Name | 6-[1-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[1-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;cyclopropanecarbonyl chloride |
| SMILES | CC(c1ccc2nc(N)cn2n1)c1nnc2ccc(Br)cn12.CC(c1ccc2nc(NC(=O)C3CC3)cn2n1)c1nnc2ccc(Br)cn12.O=C(Cl)C1CC1 |
| InChI | InChI=1S/C18H16BrN7O.C14H12BrN7.C4H5ClO/c1-10(17-23-22-16-6-4-12(19)8-25(16)17)13-5-7-15-20-14(9-26(15)24-13)21-18(27)11-2-3-11;1-8(10-3-5-12-17-11(16)7-22(12)20-10)14-19-18-13-4-2-9(15)6-21(13)14;5-4(6)3-1-2-3/h4-11H,2-3H2,1H3,(H,21,27);2-8H,16H2,1H3;3H,1-2H2 |
| InChIKey | LLUBLDYYYDTORP-UHFFFAOYSA-N |
| XLogP | 6.47 |
| TPSA | 192.95 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 55 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 889.02 |
| LogP ≤ 5 | 6.47 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 15 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'acid_halide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159388307 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.